Eurofins Discovery
Brussels, Belgium (US operations: San Diego, CA)
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (2)
○ EMA GMP
○ MHRA GMP
Quick Facts: Eurofins Discovery
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Brussels, Belgium (US operations: San Diego, CA)
- Modalities
- GPCR profiling panels, Safety pharmacology screening, Binding assays, Functional cell-based assays, ADME, In vitro pharmacology
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Eurofins Discovery
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesGPCR profiling panels, Safety pharmacology screening, Binding assays, Functional cell-based assays, ADME, In vitro pharmacology
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (6 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press2 articles
Broad modality coverage (6 modalities)
Recent News 2 articles
Innovating Obesity Drug Discovery: Trends, Challenges, and Translational Strategies - Drug Target Review
Eurofins Achieves New Record Level of Annual Revenues While Demonstrating a Strong Increase in Margins and Cash Generation and Returns to Its Pre-COVID Profitability and Cash Flow Growth Trends - Business Wire
Frequently Asked Questions About Eurofins Discovery
What is Eurofins Discovery's CDMO Signal Score?
Eurofins Discovery has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Eurofins Discovery for a manufacturing program?
Use the free AI matchmaker to compare Eurofins Discovery against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.